✦ LIBER ✦

Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity

✍ Scribed by Ossenkoppele, Gerrit J.; Wijermans, Pierre W.; Nauta, J.J.P.; Huijgens, Peter C.; Langenhuijsen, Mart M.A.C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VERY-LOW-DOSE CYTARABINE FOR MYELODYSPLA

✍ Worsley, Alison; Mufti, G.J.; Copplestone, J.A.; Oscier, D.G.; Hamblin, T.J. 📂 Article 📅 1986 🏛 The Lancet 🌐 English ⚖ 145 KB

MITOZANTRONE AND HIGH-DOSE CYTARABINE IN

✍ MARCUS, R 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 148 KB

ICSBP promoter methylation in myelodyspl

✍ Otto, N; Manukjan, G; Göhring, G; Hofmann, W; Scherer, R; Luna, J Chacon; Lehman 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 346 KB

Low dose cytosine arabinoside in the tre

✍ M. Murray; P. Sarsfield; E. Lawlor; S. R. McCann 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 337 KB

MITOZANTRONE AND HIGH-DOSE CYTARABINE IN

✍ Hiddemann, W; Kreutzmann, H; Ludwig, W.D; Aul, H.C; Donhuijsen-Ant, R; Lengfelde 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 311 KB

Low expression of the putative tumour su

✍ Jacqueline Boultwood; Andrea Pellagatti; Fiona Watkins; Lisa J. Campbell; Noor E 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB